Gene · 7114
Papers2,131
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,131
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A top-down proteomic approach reveals a salivary protein profile able to classify Parkinson's disease with respect to Alzheimer's disease patients and to healthy controls. | Proteomics | 2024 | 37541286 | PubTator, text mining | PubMed |
| Ferroptosis and Preeclampsia: Genetic Analysis of Potential Biomarkers and Therapeutic Targets. | Biochem Genet | 2024 | 37474873 | PubTator, text mining | PubMed |
| Thymosin beta-4 - A potential tool in healing middle ear lesions in adult mammals. | Int Immunopharmacol | 2023 | 38706788 | PubTator, text mining | PubMed |
| Platelet-Rich Plasma (PRP) in Dermatology: Cellular and Molecular Mechanisms of Action. | Biomedicines | 2023 | 38275368 | PubTator, text mining | PubMed |
| Identification of a novel, MSC-induced macrophage subtype via single-cell sequencing: implications for intervertebral disc degeneration therapy. | Front Cell Dev Biol | 2023 | 38274272 | PubTator, text mining | PubMed |
| Application progress of single-cell sequencing technology in mesenchymal stem cells research. | Front Cell Dev Biol | 2023 | 38264356 | PubTator, text mining | PubMed |
| FEZ1 participates in human embryonic brain development by modulating neuronal progenitor subpopulation specification and migrations. | iScience | 2023 | 38213789 | PubTator, text mining | PubMed |
| Post-translational modulation of cell signalling through protein succinylation. | Explor Target Antitumor Ther | 2023 | 38213532 | PubTator, text mining | PubMed |
| Machine learning identifies ferroptosis-related gene ANXA2 as potential diagnostic biomarkers for NAFLD. | Front Endocrinol (Lausanne) | 2023 | 38192427 | PubTator, text mining | PubMed |
| Tibetan Plateau yak milk: A comprehensive review of nutritional values, health benefits, and processing technology. | Food Chem X | 2023 | 38144800 | PubTator, text mining | PubMed |
| Proteomic profiling of human menisci from mild joint degeneration and end-stage osteoarthritis versus healthy controls. | Osteoarthr Cartil Open | 2023 | 38098679 | PubTator, text mining | PubMed |
| Unravelling cancer subtype-specific driver genes in single-cell transcriptomics data with CSDGI. | PLoS Comput Biol | 2023 | 38096269 | PubTator, text mining | PubMed |
| Harnessing stem cell and lineage reprogramming technology to treat cardiac fibrosis. | Cell Regen | 2023 | 38072904 | PubTator, text mining | PubMed |
| Cell Therapy in the Treatment of Coronary Heart Disease. | Int J Mol Sci | 2023 | 38069167 | PubTator, text mining | PubMed |
| Actin Isoform Composition and Binding Factors Fine-Tune Regulatory Impact of Mical Enzymes. | Int J Mol Sci | 2023 | 38068973 | PubTator, text mining | PubMed |
| Delineating the early dissemination mechanisms of acral melanoma by integrating single-cell and spatial transcriptomic analyses. | Nat Commun | 2023 | 38065972 | PubTator, text mining | PubMed |
Integrating bulk and single-cell RNA sequencing data reveals epithelial-mesenchymal transition molecular subtype and signature to predict prognosis, immunotherapy efficacy, and drug candidates in low-grade gliomas. | Front Pharmacol | 2023 | 38053842 | PubTator, text mining | PubMed |
| Spatial transcriptomics deconvolution at single-cell resolution using Redeconve. | Nat Commun | 2023 | 38040768 | PubTator, text mining | PubMed |
| Proteomic analysis of salivary inflammatory biomarkers of developmental gingival enlargements in patients with West and Noonan syndromes: a preliminary pilot single-center retrospective study. | Eur Rev Med Pharmacol Sci | 2023 | 38039040 | PubTator, text mining | PubMed |
| TMSB4X: A novel prognostic marker for non-small cell lung cancer. | Heliyon | 2023 | 38027718 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7114/papers?page=6